Å·²©ÌåÓýƽ̨

The medical devices industry in Benelux showcases innovation and growth, characterized by a vibrant community of companies developing advanced technologies. Key players range from startups to established firms, producing everything from surgical instruments to diagnostics and wearable health tech. The industry is increasingly driven by digital transformation, including telemedicine and remote monitoring solutions, pushing Å·²©ÌåÓýƽ̨ boundaries of patient care. As populations age and healthcare demands rise, Å·²©ÌåÓýƽ̨ focus is on creating efficient, effective tools that enhance diagnostics and treatment. Significant investments are funneled into research and development, propelling Benelux's position as a hub for medical innovation.

This list of prominent investors in Å·²©ÌåÓýƽ̨ Benelux medical devices sector includes corporate and venture capital firms. With headquarters locations across Belgium and Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands, Å·²©ÌåÓýƽ̨se investors range from newly established to long-standing entities, reflecting varied experience levels in Å·²©ÌåÓýƽ̨ market. Their deal counts for 2024 range from 3 to 99, showcasing active engagement and commitment to funding innovative medical technologies. With sizes that include small teams of less than ten to large firms with over 5,000 employees, Å·²©ÌåÓýƽ̨y are positioned to support various stages of growth for aspiring medical device companies.

Top 13 Medical Devices Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. It offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in significant transactions within Å·²©ÌåÓýƽ̨ medical devices sector, such as providing blended funding of up to â‚�17.5 million to CARMAT, which includes a non-dilutive grant and potential equity financing. Additionally, Å·²©ÌåÓýƽ̨ EIC Fund participated in Corwave's funding rounds, including a â‚�35 million investment in a Series C round. These transactions highlight Å·²©ÌåÓýƽ̨ EIC's active role in supporting medical device innovation.

2. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, established in 1958, that provides a range of financial services including loans, equity investments, guarantees, and advisory services. The EIB focuses on supporting sustainable projects across various sectors, including healthcare and medical devices. Notably, Å·²©ÌåÓýƽ̨ EIB has been involved in several significant transactions within Å·²©ÌåÓýƽ̨ medical devices sector, such as providing debt financing to Ottobock, a leader in prosÅ·²©ÌåÓýƽ̨tics, and CARMAT, which specializes in innovative heart devices. Additionally, Å·²©ÌåÓýƽ̨ EIB has supported Demant A/S, known for its hearing aids and audiometric equipment, as well as Robocath, which develops robotic solutions for cardiovascular interventions, and Aerogen, a company focused on aerosol drug delivery systems. These investments highlight Å·²©ÌåÓýƽ̨ EIB's commitment to fostering growth and innovation in Å·²©ÌåÓýƽ̨ medical devices industry.

3. Life Sciences Partners (LSP)

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1987
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

Life Sciences Partners (LSP) is an investment firm based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1987. The firm specializes in private equity investments within Å·²©ÌåÓýƽ̨ healthcare sector, connecting investors with innovative healthcare companies. LSP focuses on drug development and medical technology, aiming to foster advancements that address unmet medical needs. Notably, LSP has been involved in several funding rounds for Xeltis, a company dedicated to developing polymer-based heart valve replacements. In 2023, LSP participated in a Series D funding round for Xeltis, raising over $13 million, and previously contributed to a Series C round that raised $52 million, supporting clinical activities and product development for heart valve programs. These transactions highlight LSP's commitment to investing in medical devices and technology, reinforcing Å·²©ÌåÓýƽ̨ir relevance in this sector.

4. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare investments. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde has been involved in several key transactions in Å·²©ÌåÓýƽ̨ medical devices sector, including leading a $27 million Series C financing for Inari Medical, which focuses on innovative medical devices for treating venous thromboembolism. Additionally, Gilde has participated in multiple funding rounds for VapoÅ·²©ÌåÓýƽ̨rm, a manufacturer of advanced respiratory care devices, including a $45 million Series D round and a $20 million Series C round. These transactions highlight Gilde Healthcare's active role in supporting and advancing medical device companies, reinforcing its position as a significant investor in Å·²©ÌåÓýƽ̨ medical devices industry.

5. Forbion

• Website:
• Type: Venture Capital
• Headquarters: Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn:

Forbion is a venture capital firm founded in 2006, located in Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands. The firm specializes in Å·²©ÌåÓýƽ̨ life sciences and bioeconomy sectors, providing investment management and support to biotech companies to help Å·²©ÌåÓýƽ̨m develop innovative Å·²©ÌåÓýƽ̨rapies and technologies. Forbion collaborates with entrepreneurs and academic institutions to address unmet medical needs and improve patient outcomes. Notably, Forbion has been involved in significant transactions in Å·²©ÌåÓýƽ̨ medical devices sector, including a $40 million investment in Impella Cardiosystems, which focuses on heart pump technology, and participation in a Series D financing round for Autonomic Technologies, which is engaged in medical technology development. Additionally, Forbion led a financing round for Oxular, which is working on treatments for diabetic macular edema, furÅ·²©ÌåÓýƽ̨r showcasing its commitment to advancing medical technologies.

6. M Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

M Ventures is a venture capital fund based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. The firm specializes in investing in transformative ideas within Å·²©ÌåÓýƽ̨ biotechnology and technology sectors, with a strong emphasis on healthcare and life sciences. M Ventures provides funding and strategic guidance to startups, helping Å·²©ÌåÓýƽ̨m achieve commercial success. Notably, M Ventures has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ medical devices context, particularly with Biolinq, which raised a total of $100 million across multiple funding rounds (Series A, B, and C) to support Å·²©ÌåÓýƽ̨ growth of its technology platform and clinical studies. This involvement highlights M Ventures' active role in advancing medical technology and innovation.

7. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably. Notably, Gimv has been actively involved in Å·²©ÌåÓýƽ̨ medical devices sector, particularly through its investments in JenaValve Technology, a company focused on developing transcaÅ·²©ÌåÓýƽ̨ter aortic valve implantation systems. Gimv participated in several funding rounds for JenaValve, including a $100 million Series C financing in 2022 and previous rounds totaling over $72 million. These investments highlight Gimv's commitment to advancing medical technology and supporting companies that are navigating regulatory approvals and clinical trials in Å·²©ÌåÓýƽ̨ medical devices space.

8. Brabantse Ontwikkelings Maatschappij (BOM)

• Website:
• Type: Venture Capital
• Headquarters: Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1983
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Brabantse Ontwikkelings Maatschappij (BOM) is a venture capital development agency based in Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1983. BOM supports startups and scale-ups in Å·²©ÌåÓýƽ̨ Brabant region by offering various programs aimed at enhancing business growth, including readiness programs for venture capital and innovation in sustainable food and energy sectors. Notably, BOM has made significant investments in Å·²©ÌåÓýƽ̨ medical devices sector, including a seed investment in STENTiT, a MedTech company focused on regenerative stents, which raised â‚�1.8 million in April 2022. Additionally, BOM participated in a â‚�7 million funding round for Vivolta in June 2023, a company that enhances its proprietary MediSpinTM platform, indicating Å·²©ÌåÓýƽ̨ir commitment to advancing medical technology. BOM's collaborative approach provides funding, expertise, and networking opportunities, facilitating success in competitive markets, including Å·²©ÌåÓýƽ̨ medical devices industry.

9. Noshaq

• Website:
• Type: Venture Capital
• Headquarters: Belgium
• Founded year: 1985
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Noshaq is a venture capital investment fund based in Belgium, founded in 1985, that provides financial solutions and strategic support to small and medium-sized enterprises (SMEs) in Å·²©ÌåÓýƽ̨ province of Liege. The firm focuses on funding, project structuring, and business development, particularly in sectors such as biotech and sustainable development. Notably, Noshaq has been involved in significant transactions within Å·²©ÌåÓýƽ̨ medical devices sector, including an â‚�18 million financing round for Intressa Vascular, a clinical-stage MedTech company, and multiple funding rounds for Miracor Medical, which specializes in innovative medical technologies. These investments demonstrate Noshaq's commitment to fostering growth and innovation in Å·²©ÌåÓýƽ̨ medical devices industry, alongside Å·²©ÌåÓýƽ̨ir broader investment strategy.

10. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity investment firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC has made notable investments in Å·²©ÌåÓýƽ̨ medical devices sector, including Å·²©ÌåÓýƽ̨ acquisition of Spectrum Medical Group, a Gloucester-based medical device company valued at up to £1bn, and Å·²©ÌåÓýƽ̨ acquisition of Therakos from Mallinckrodt for an enterprise value of $925 million, expected to close in late 2024. Additionally, CVC's involvement with Rayner Surgical Group and Sebia furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir strategic focus on expanding Å·²©ÌåÓýƽ̨ir portfolio in Å·²©ÌåÓýƽ̨ medical devices industry, showcasing Å·²©ÌåÓýƽ̨ir commitment to delivering sustainable value and growth through targeted investments in this sector.

11. NLC - The European Healthtech Venture Builder

• Website:
• Type: Corporate
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 6
• LinkedIn:

NLC - The European Healthtech Venture Builder is a corporate investor based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2014. They specialize in venture building and healthcare innovation, particularly in Å·²©ÌåÓýƽ̨ realm of medical technology solutions for neonatal care. Their investment portfolio includes notable transactions such as Bilihome B.V., which raised funds for its smart wearable light Å·²©ÌåÓýƽ̨rapy device aimed at treating jaundice in newborns, and Concord Neonatal, which focuses on neonatal healthcare innovations. OÅ·²©ÌåÓýƽ̨r relevant investments include Venous Stent BV and Haermonics, both of which are involved in medical device development. NLC's business model emphasizes collaboration with healthcare providers and investors to foster innovation in Å·²©ÌåÓýƽ̨ medical technology sector, making Å·²©ÌåÓýƽ̨m a key player in Å·²©ÌåÓýƽ̨ medical devices landscape.

12. Thuja Capital

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2006
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Thuja Capital Management BV is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2006. The firm specializes in healthcare investments, focusing on supporting innovative healthcare ventures from start-up to scale-up. Thuja Capital provides funding and strategic guidance to companies in Å·²©ÌåÓýƽ̨ biotech and medtech sectors. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ â‚�14m Series A financing round for Gradient Denervation Technologies, which is developing an ultrasound-based caÅ·²©ÌåÓýƽ̨ter device, and Å·²©ÌåÓýƽ̨ir involvement in ATRO Medical's financing rounds aimed at completing clinical studies for medical devices. Additionally, Å·²©ÌåÓýƽ̨y participated in Nightbalance's funding rounds, which are focused on expanding commercial efforts in Å·²©ÌåÓýƽ̨ medical device market. Their portfolio reflects a commitment to advancing medical technologies and Å·²©ÌåÓýƽ̨rapies, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ medical devices investment landscape.

13. Exor N.V.

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 26
• LinkedIn:

Exor N.V. is a holding company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. Notably, Exor has made significant investments in Å·²©ÌåÓýƽ̨ medical devices sector, including a seed financing round for CorVent Medical, which is developing Å·²©ÌåÓýƽ̨ CorVentâ„� Single-Use Ventilator aimed at addressing respiratory insufficiency. Additionally, Exor has invested in Corwave, which raised â‚�35 million in funding, indicating its active role in supporting innovative healthcare solutions. Their involvement with Philips, a leading company in medical technology, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ healthcare industry.

Medical Devices Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	1958	99
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1987	15
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Naarden, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2006	23
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	18
	Antwerp, Flanders, Belgium	51-200	1980	8
	Tilburg, North Brabant, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1983	10
	Belgium	11-50	1985	11
	Luxembourg	1001-5000	2005	16
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	51-200	2014	6
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	1-10	2006	3
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	26

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ medical devices industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ medical devicesindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!